Journal Updates
eMediNexus Coverage from: 
Experimental vaccine may reduce risk of blood clot post-stroke
eMediNexus,  31 October 2018
remove_red_eye 745 Views
#Cardiology #Pharmacist #Public Health

1 Read Comments                

An experimental vaccine - S100A9 - may one day be able to replace oral blood thinners to reduce the risk of secondary strokes caused by blood clots, without increasing the risk of serious bleeding or triggering an autoimmune response, according to new research in the journal Hypertension, reported online Oct. 29, 2018. The vaccine was found to be as safe and effective as one of the most widely used oral blood thinners currently used to reduce clotting risk.

To comment on this article,
create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies
Create Account

Already registered?

Login Now